Sigma-Aldrich

hgDPF-j4_400x400Sigma-Aldrich produces a Delta 9 THC solution according to product information found on their website.  They are also keenly aware of the Therapeutic value of Cannabinoids.  As early as 1998 Sigma-Aldrich new of the value of Cannabinoids in the treatment of all kinds of health issues.

US DEA Schedule I

Home Office Schedule 2

stupéfiant; kontrollierte Droge in Deutschland;

regulated under CDSA – not available from Sigma-Aldrich Canada

Sigma Aldrich Website link

Product Specifications document – T2386-SIGMA-

Sigma-Aldrich Cannabinoid information section – LINKCannabinoid Receptors | Sigma-Aldrich

Sigma-Aldrich Research

  1. Marihuana and cannobinoids as medicaments – LINKMarihuana and cannobinoids as medicaments Sigma-Aldrich
  2. An ultra-low dose of tetrahydrocannabinol provides cardioprotection – LinkAn ultra-low dose of tetrahydrocannabinol provides cardioprotection. | Sigma-Aldrich
  3. Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants. – LINKCannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants. | Sigma-Aldrich
  4. Cannabis medicines in Norway–the basis for approval, published Dec 2012 – LINK – Abstract removed
  5. Induction of the fatty acid 2-hydroxylase (FA2H) gene by Δ(9)-tetrahydrocannabinol in human breast cancer cells. published Journal of Toxicological Sciences 2013-01-01  – LINKInduction of the fatty acid 2-hydroxylase (FA2H) gene by Δ(9)-tetrahydrocannabinol in human breast cancer cells. | Sigma-Aldrich

** NOTE** We have tried to get confirmation or denial from Sigma-Aldrich but no one is able to answer the question on what sort of research they have underway.